MOXY PEREZ COLEY: Open Payments
NPI 1780345330 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 30 payments from 19 companies in 2025. Trend: 2023 $287 · 2024 $0 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 3 | $74 |
| Daiichi Sankyo Inc. | 3 | $71 |
| Merck Sharp & Dohme LLC | 2 | $57 |
| Gilead Sciences, Inc. | 2 | $55 |
| Janssen Biotech, Inc. | 2 | $46 |
| SOBI, INC | 2 | $45 |
| ARRAY BIOPHARMA INC | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| ARGENX US, INC. | 1 | $32 |
Products named: REBLOZYL, Enhertu, Trodelvy, TREMFYA, Vonjo, BRAFTOVI, NEXLETOL, VYVGART HYTRULO.
Industry payments across TX — which companies pay providers there.
